Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10-17
SponsorFondation Lenval

About this trial

This study aims to identify perceived barriers and facilitators to regular physical activity among children and adolescents with inflammatory bowel disease (IBD) followed in pediatric gastroenterology. Approximately 60 participants aged 10-17 years will complete two self-administered questionnaires (CAPAS-Q for physical activity/sedentary behavior and IMPACT-III for health-related quality of life) and take part in a single semi-structured interview exploring experiences, obstacles, and levers to support sustainable physical activity. Relevant clinical data (disease characteristics, treatment and selected routine clinical parameters) will be extracted from the medical record. Participation is limited to one visit (about 45-60 minutes) during a routine hospital appointment, with no additional intervention or follow-up required.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 10 to 17 years at inclusion.

Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months.

Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice).

Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview.

Disqualifiers

Younger than 10 years or older than 17 years.

No IBD diagnosis, or IBD diagnosed less than 6 months ago.

Associated chronic condition (neurological, metabolic, psychiatric, or other) likely to interfere with questionnaire completion or interview participation.

Major language or cognitive impairment preventing adequate understanding or interview participation.

Trial population

Aged 10 to 17 years at inclusion. * Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months. * Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice). * Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • IMPACT-III questionnaires

    Other intervention

    Participants complete the self-administered questionnaires IMPACT-III)

  • Data collection: CAPAS-Q

    Other intervention

    Participants complete the self-administered questionnaires CAPAS-Q.

  • semi-structured interview

    Other intervention

    participate in a semi-structured interview about perceived barriers and facilitators to physical activity. No counseling, training, or treatment is provided.

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Pediatric IBD participants (questionnaires + interview)3 interventions

Trial outcomes

Primary outcomes

1

Perceived barriers and facilitators to regular physical activity

Assessed through a single semi-structured interview. Qualitative thematic analysis will be used to identify and categorize perceived barriers and facilitators to regular physical activity in pediatric IBD.

Time frame
at the inclusion

Secondary outcomes

1

Physical activity level and sedentary behavior (CAPAS-Q)

Measured using the CAPAS-Q self-administered questionnaire to describe participants' physical activity and sedentary behavior.

Time frame
at the inclusion
2

Health-related quality of life (IMPACT-III)

Measured using the IMPACT-III self-administered questionnaire to assess health-related quality of life in pediatric IBD.

Time frame
at the inclusion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.